SCHEMBL1745723

SCHEMBL1745723

C=C(c1ccccc1)c1cccc(C=O)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ UNG P13051 1/20 0.63
▸ ALDH1A1 P00352 4/20 0.48
▸ CYP2A6 P11509 1/20 0.48
▸ TRIM24 O15164 1/20 0.46
▸ TRIM33 Q9UPN9 1/20 0.46
▸ KDR P35968 2/20 0.42
▸ CHEK1 O14757 1/20 0.42
▸ MAOB P27338 3/20 0.41
▸ MAOA P21397 1/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ NAT1 P18440 1/20 0.40
▸ SRC P12931 1/20 0.40
▸ TTR P02766 1/20 0.39
▸ TDP1 Q9NUW8 2/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ ATM Q13315 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ AKR1C1 Q04828 1/20 0.37
▸ PLIN1 O60240 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzaldehyde SCHEMBL27303989 0.88 ALDH1A1 (0.64) UNGALDH1A1CYP2A6TRIM24TRIM33
SCHEMBL7786381 0.82 ALDH1A1 (0.50) UNGALDH1A1KDRCHEK1MAOB
SCHEMBL17521331 0.82 ALDH1A1 (0.56) UNGALDH1A1CYP2A6TRIM24TRIM33
SCHEMBL22466383 0.80 UNG (0.74) UNGALDH1A1CYP2A6TRIM24TRIM33
SCHEMBL6120523 0.80 UNG (0.49) UNGALDH1A1CYP2A6TRIM24TRIM33
SCHEMBL814654 0.79 MEN1 (0.52) ALDH1A1KDRCHEK1MAOBMAOA
SCHEMBL1044596 0.78 UNG (0.71) UNGALDH1A1CYP2A6TRIM24TRIM33
SCHEMBL9291451 0.78 UNG (0.60) UNGALDH1A1CYP2A6TRIM24TRIM33
SCHEMBL19737184 0.78 UNG (0.60) UNGALDH1A1CYP2A6TRIM24TRIM33
3-Formylbenzoic Acid SCHEMBL29514486 0.78 UNG (1.00) UNGALDH1A1TRIM24TRIM33TTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1559422-B1 RECEPTOR FUNCTION CONTROLLING AGENT TAKEDA PHARMACEUTICAL (JP) 2014-04-30 — — EP disclosed
US-8680150-B2 Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors LIGAND PHARMACEUTICALS, INC. (US) 2014-03-25 — — US disclosed
EP-2385032-A1 GPR40 Receptor function regulator Takeda Pharmaceutical Company Limited (JP) 2011-11-09 — — EP disclosed
US-7960369-B2 Receptor function regulator TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-06-14 — — US disclosed
US-20110003851-A1 SMALL MOLECULE HEMATOPOIETIC GROWTH FACTOR MIMETIC COMPOUNDS THAT ACTIVATE HEMATOPOIETIC GROWTH FACTOR RECEPTORS LIGAND PHARMACEUTICALS, INC. (US) 2011-01-06 — — US disclosed
US-20090012093-A1 Receptor Function Regulator TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-01-08 — — US disclosed
CN-1735408-A Receptor function controlling agent TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2006-02-15 — — CN disclosed
EP-1559422-A1 RECEPTOR FUNCTION CONTROLLING AGENT Takeda Pharmaceutical Company Limited (JP) 2005-08-03 — — EP disclosed
US-4504491-A INSECTICIDE NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1985-03-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090012093-A1 Receptor Function Regulator GPR119, GIPR, INSR UNG 4816/4885ALDH1A1 4258/4885CYP2A6 3397/4885
US-20110003851-A1 SMALL MOLECULE HEMATOPOIETIC GROWTH FACTOR MIMETIC COMPOUNDS THAT ACTIVATE HEMATOPOIETIC GROWTH FACTOR RECEPTORS MPL, CSF3R, CSF1R UNG 4692/4885ALDH1A1 3164/4885CYP2A6 4472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback